Pharma Focus Asia
Overview
Pharma Focus Asia is an English-language pharmaceutical industry magazine published from Hyderabad, Telangana, by Ochre Media — now styled Ochre Digi Media Pvt. Ltd. It is a business-to-business title written for the executives who run pharmaceutical companies, and it covers the issues and trends shaping the industry across Asia and, in its own description, the rest of the world. In print and digital versions, it presents itself as a leading pharma title serving the information needs of key executives from the world's leading pharmaceutical companies.
The magazine's promise to readers is twofold: dedicated, reliable and accurate coverage of the industry's progress, and analysis sharp enough to help readers make informed decisions and stay ahead of competition. Its content is deliberately forward-looking — described by the publisher as cutting-edge and futuristic — and it is organised into clear professional sections so that a manufacturing head, a clinical researcher or a strategist can each find material written for their part of the business.
Publisher and Editorial Home
Ochre Media is a Hyderabad-based B2B media company that describes itself as an online digital solutions specialist in business-to-business commerce, with a presence across print and web media and a clientele drawn from across the globe. Pharma Focus Asia is its pharmaceutical flagship, produced from the company's offices in the White House building at Kundanbagh, Begumpet, Hyderabad — an address printed in the magazine's own masthead as Units 110, 111 and 112, First Floor, Block II, White House, Hyderabad 500016, Telangana.
The magazine's masthead in a recent issue (Issue 61, 2025) names Prasanthi Sadhu as editor, supported by an editorial team, an art director, a product manager and business-events, circulation and subscriptions staff — the structure of a full B2B publishing operation rather than a newsletter. An international advisory board, drawn from pharmaceutical companies, consultancies and service providers in Asia, Europe and beyond, lends the title an explicitly cross-border character that matches its name.
Frequency and Formats
Pharma Focus Asia is currently described by its publisher as a quarterly publication, appearing in both print and digital versions; earlier descriptions of the title have at times called it half-yearly or bi-annual, reflecting changes in frequency over its life. By 2025 the magazine had reached Issue 61, a numbering that testifies to a long run of regular publication.
The print magazine is only one layer of the product. The website, pharmafocusasia.com, carries the complete content of the magazine and is updated daily with pharma news, press releases, industry reports, interviews, trends and events. The magazine is supplemented by a monthly e-newsletter, Verticaltalk Pharma, which keeps its audience in touch between issues. Registered readers on the website can read full issues and member articles, download application notes, whitepapers and special reports, save articles to a reading list and subscribe to topic alerts in areas such as GxP, quality control, data integrity, automation and analytics.
Subject Coverage and Sections
Each issue of Pharma Focus Asia is broadly organised into sections that map the pharmaceutical value chain. Strategy covers business direction, markets and corporate decision-making. Research and Development follows drug discovery and product development. Manufacturing addresses production technology, facilities and the practical business of making medicines. Clinical Trials examines how new products are tested and evidenced. Information Technology covers the digital systems on which modern pharma increasingly runs. Some descriptions of the magazine add an Expert Talk element, in which industry specialists address readers directly.
Within those sections, coverage ranges across pharmaceutical business, manufacturing technology, research and regulatory developments — the four broad territories named in standard descriptions of the title. The result is a magazine that treats pharma as an integrated industry: a change in regulation, a new manufacturing platform and a corporate strategy shift are all part of the same reader's working world, and the magazine is arranged accordingly.
Audience and Readership
The readership of Pharma Focus Asia is explicitly senior. The publisher describes it as including top C-level executives, senior industry executives and the key decision-makers in the pharmaceutical industry who are in charge of spending. That positioning — readers with budgets, not just interest — is the commercial foundation of B2B publishing, and it shapes the magazine's content toward analysis, technology evaluation and strategic intelligence rather than general news.
Geographically, although the title is published from India and focuses specially on Asia, its stated reach extends to industry leaders across Asia, Europe and the Americas. Its professional social media presence reflects that audience: the magazine's LinkedIn page, categorised under pharmaceutical manufacturing and based in Hyderabad, has attracted several thousand followers from the industry.
Asia Focus in a Global Industry
The "Asia" in the title is a deliberate editorial choice. Asia is home to some of the world's most important pharmaceutical manufacturing centres — India prominent among them — and to fast-growing healthcare markets whose regulatory and commercial conditions differ from those of Europe and North America. A magazine edited from Hyderabad, itself one of India's great pharmaceutical clusters, is well placed to cover that terrain from inside it.
At the same time, the magazine does not confine itself to Asia. Its advisory board and coverage reach into Europe and the Americas, reflecting the reality that Asian pharma companies sell globally, comply with global regulators and compete with global rivals. Pharma Focus Asia therefore works as a bridge publication: Asian in base and emphasis, international in sources and readership.
Digital Presence and Newsletter
The website is described by the publisher as a one-stop pharma destination. Beyond reproducing the magazine, it functions as a daily news and resources service for the industry, with press releases, reports, interviews and event information that a quarterly print cycle could never carry at speed. For readers, registration unlocks the deeper resources — full issues, whitepapers, application notes and special reports — turning the site into a working library on manufacturing, quality and digital transformation.
Verticaltalk Pharma, the monthly e-newsletter, is the connective tissue of the brand, maintaining monthly contact with an audience that receives the magazine itself quarterly. Together with the group's wider digital marketing services — Ochre offers e-blasts, e-newsletters, lead generation and related B2B services — the title exemplifies how specialist print magazines have become multi-channel information brands.
Events and Industry Services
The masthead's inclusion of a business-events function reflects another strand of the operation. Ochre Media's activities around the title include event marketing and sponsorships, and the magazine's pages and website carry pharma events coverage for the industry community it serves. For a B2B audience, conferences and exhibitions are where business is done, and a magazine that reports events, promotes them and participates in the circuit becomes part of the industry's infrastructure.
The publisher's service listings also point to interviews and expert-talk formats, industry reports and print and digital advertising as core offerings — the standard commercial repertoire of a trade title whose value to advertisers lies in the seniority of its readership.
Role in Pharmaceutical Trade Media
Pharma Focus Asia occupies a distinct place among Indian-published industry magazines: where many trade titles serve a national market, this one was conceived regionally, addressing the pharmaceutical industry of a continent from an Indian base. For executives in Asian pharma — and for global companies watching Asia — it offers coverage in which the region is the centre of the story rather than an outpost of it.
Its sectional structure, advisory board and multi-format delivery also illustrate the modern B2B formula: authoritative print issues for considered reading, a daily website for news, a newsletter for retention, and downloadable technical resources for working use. Sixty-one issues in, that formula has made the magazine a familiar fixture of the Asian pharmaceutical business landscape.
How to Read and Subscribe
Readers can access Pharma Focus Asia through its print and digital editions and in full on its website, pharmafocusasia.com, where current magazine content, news and resources are posted and registration provides access to complete issues and member material. The monthly Verticaltalk Pharma newsletter offers a lighter, regular route into the same coverage.
Subscription, advertising and events enquiries are handled by Ochre Digi Media from its Begumpet, Hyderabad offices, whose address and contact details are printed in the magazine itself. For pharmaceutical executives in Asia and those doing business with the region, it remains a purpose-built source of industry intelligence from one of India's pharma capitals.
